Rotavirus in adults requiring hospitalization

Journal of Infection

Volumn 64, Issue 1, 2012, Pages 89-95

  Anderson, Evan J ^a   Katz, Ben Z ^a   Polin, Jennifer A ^a   Reddy, Susheel ^a   Weinrobe, Melissa H ^a   Noskin, Gary A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adult; Genotypes; Immunocompromised; Pediatric; Rotavirus

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CAMPYLOBACTER; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; FECES CULTURE; FEMALE; GENOTYPE; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RISK FACTOR; ROTAVIRUS; ROTAVIRUS INFECTION; SALMONELLA; SHIGELLA; UNITED STATES; VIRUS DETECTION;

ADULT; AGED; AGED, 80 AND OVER; CHICAGO; COHORT STUDIES; DIARRHEA; FECES; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; ROTAVIRUS; ROTAVIRUS INFECTIONS;

EID: 84455188948     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.09.003     Document Type: Article

References (31)

1. Mounts A.W., Holman R.C., Clarke M.J., Bresee J.S., Glass R.I. Trends in hospitalizations associated with gastroenteritis among adults in the United States, 1979-1995. Epidemiol Infect 1999, 123(1):1-8.
2. Guerrant R.L., Van Gilder T., Steiner T.S., Thielman N.M., Slutsker L., Tauxe R.V., et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001, 32(3):331-351.
3. Kapikian A.Z. Viral gastroenteritis. JAMA 1993, 269(5):627-630.
4. Glass R.I., Parashar U.D., Bresee J.S., Turcios R., Fischer T.K., Widdowson M.A., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006, 368(9532):323-332.
5. Anderson E. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis 2008, 8:642-649.
6. Velazquez F.R., Matson D.O., Calva J.J., Guerrero L., Morrow A.L., Carter-Campbell S., et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996, 335(14):1022-1028.
7. Anderson E.J., Weber S.G. Rotavirus infection in adults. Lancet Infect Dis 2004, 4(2):91-99.
8. Lopman B.A., Hall A.J., Curns A.T., Parashar U.D. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis 2011, 52(4):466-474. Epub 2011/01/25.
9. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370(9601):1757-1763.
10. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(1):11-22.
11. Linhares A.C., Velazquez F.R., Perez-Schael I., Saez-Llorens X., Abate H., Espinoza F., et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008, 371(9619):1181-1189.
12. DiStefano D.J., Kraiouchkine N., Mallette L., Maliga M., Kulnis G., Keller P.M., et al. Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis. J Clin Microbiol 2005, 43(12):5876-5880.
13. Das B.K., Gentsch J.R., Cicirello H.G., Woods P.A., Gupta A., Ramachandran M., et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 1994, 32(7):1820-1822.
14. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992, 30(6):1365-1373.
15. Anderson E.J., Rupp A., Shulman S.T., Wang D., Zheng X., Noskin G.A. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics 2011, 127(2):e264-e270. Epub 2011/01/26.
16. Ethelberg S., Olsen K.E., Gerner-Smidt P., Molbak K. The significance of the number of submitted samples and patient-related factors for faecal bacterial diagnostics. Clin Microbiol Infect 2007, 13(11):1095-1099.
17. Scallan E., Jones T.F., Cronquist A., Thomas S., Frenzen P., Hoefer D., et al. Factors associated with seeking medical care and submitting a stool sample in estimating the burden of foodborne illness. Foodborne Pathog Dis 2006, 3(4):432-438.
18. Pitzer V.E., Viboud C., Simonsen L., Steiner C., Panozzo C.A., Alonso W.J., et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (New York, NY 2009, 325(5938):290-294.
19. Tate J.E., Panozzo C.A., Payne D.C., Patel M.M., Cortese M.M., Fowlkes A.L., et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009, 124(2):465-471.
20. Thomas P.D., Pollok R.C., Gazzard B.G. Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome. HIV Med 1999, 1(1):19-24.
21. Wenman W.M., Hinde D., Feltham S., Gurwith M. Rotavirus infection in adults. Results of a prospective family study. N Engl J Med 1979, 301(6):303-306.
22. Kim H.W., Brandt C.D., Kapikian A.Z., Wyatt R.G., Arrobio J.O., Rodriguez W.J., et al. Human reovirus-like agent infection. Occurrence in adult contacts of pediatric patients with gastroenteritis. JAMA 1977, 238(5):404-407.
23. Payne D.C., Staat M.A., Edwards K.M., Szilagyi P.G., Gentsch J.R., Stockman L.J., et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008, 122(6):1235-1243.
24. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005, 15(1):29-56.
25. Gentsch J.R., Hull J.J., Teel E.N., Kerin T.K., Freeman M.M., Esona M.D., et al. G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J Infect Dis 2009, 200(Suppl. 1):S99-S105.
26. Cunliffe N.A., Ngwira B.M., Dove W., Nakagomi O., Nakagomi T., Perez A., et al. Serotype g12 rotaviruses, Lilongwe, Malawi. Emerg Infect Dis 2009, 15(1):87-90.
27. Rahman M., Sultana R., Ahmed G., Nahar S., Hassan Z.M., Saiada F., et al. Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg Infect Dis 2007, 13(1):18-24.
28. Dennehy P.H., Gauntlett D.R., Tente W.E. Comparison of nine commercial immunoassays for the detection of rotavirus in fecal specimens. J Clin Microbiol 1988, 26(9):1630-1634.
29. Dennehy P.H., Gauntlett D.R., Spangenberger S.E. Choice of reference assay for the detection of rotavirus in fecal specimens: electron microscopy versus enzyme immunoassay. J Clin Microbiol 1990, 28(6):1280-1283.
30. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(1):23-33.
31. Koopman J.S., Monto A.S. The Tecumseh study. XV: rotavirus infection and pathogenicity. Am J Epidemiol 1989, 130(4):750-759.